Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 16.6 NOK 0.91% Market Closed
Market Cap: 847.8m NOK

Operating Margin
Arcticzymes Technologies ASA

-1.4%
Current
20%
Average
-6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.4%
=
Operating Profit
-1.4m
/
Revenue
104.4m

Operating Margin Across Competitors

Arcticzymes Technologies ASA
Glance View

Market Cap
839.5m NOK
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

AZT Intrinsic Value
18.13 NOK
Undervaluation 8%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.4%
=
Operating Profit
-1.4m
/
Revenue
104.4m
What is the Operating Margin of Arcticzymes Technologies ASA?

Based on Arcticzymes Technologies ASA's most recent financial statements, the company has Operating Margin of -1.4%.

Back to Top